C12N 2501/33
Insulin
C12N2501/33 (Insulin) appears on 347 US grants and 694 published applications in this corpus.
Search patents in C12N- Granted patents
- 347
- Published applications
- 694
- Assignees
- 411
- Inventors
- 1,424
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 10 | 0 |
| 1997 | 5 | 0 |
| 1998 | 4 | 0 |
| 1999 | 8 | 0 |
| 2000 | 9 | 0 |
| 2001 | 2 | 1 |
| 2002 | 3 | 8 |
| 2003 | 5 | 11 |
| 2004 | 2 | 13 |
| 2005 | 3 | 22 |
| 2006 | 6 | 14 |
| 2007 | 3 | 20 |
| 2008 | 4 | 16 |
| 2009 | 15 | 22 |
| 2010 | 7 | 18 |
| 2011 | 9 | 19 |
| 2012 | 9 | 19 |
| 2013 | 7 | 25 |
| 2014 | 14 | 37 |
| 2015 | 19 | 37 |
| 2016 | 20 | 36 |
| 2017 | 25 | 32 |
| 2018 | 17 | 25 |
| 2019 | 17 | 47 |
| 2020 | 14 | 36 |
| 2021 | 15 | 41 |
| 2022 | 14 | 31 |
| 2023 | 19 | 50 |
| 2024 | 13 | 44 |
| 2025 | 18 | 38 |
| 2026 | 14 | 32 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Haematopoietic stem/progenitor cells29 Sep 2026US 12,747,424 B2Murdoch Childrens Research Institute
- Methods and compositions for generating oligodendrocyte progenitor cells8 Sep 2026US 12,729,368 B2Trailhead Biosystems Inc.
- Process for manufacturing of antigen-specific T lymphocytes8 Sep 2026US 12,729,369 B2Gdanski Uniwersytet Medyczny
- And efficient method for reprogramming blood to induced pluripotent stem cells14 Jul 2026US 12,680,082 B2Cedars-Sinai Medical Center
- Methods of generating oligodendrocytes23 Jun 2026US 12,661,329 B2Hadasit Medical Research Services and Development Ltd.
- Composition containing extracellular matrix and matrix-bound vesicles for producing extracellular matrix and preparation method therefor24 Sep 2026US 2026/0286308 A1Hlb Cell Co., Ltd
- Thyrocytes and uses thereof17 Sep 2026US 2026/0275279 A1LifeNet Health
- Maturation medium compositions and methods for human heart organoid maturation17 Sep 2026US 2026/0275292 A1Board of Trustees of Michigan State University
- Engineered cells and methods of use3 Sep 2026US 2026/0256838 A1The Regents of the University of California
- Metabolic selection for glycogen-storing cells in vitro3 Sep 2026US 2026/0258368 A1The Board of Trustees of the Leland Stanford Junior University
Most cited
By later US patents
- Three-dimensional cell and tissue culture system322US 4,963,489 AMarrow-Tech Incorporated · 1990
- Adipose-derived stem cells and lattices313US 6,777,231 B1The Regents of the University of California · 2004
- Three-dimensional cartilage cultures289US 5,902,741 AAdvanced Tissue Sciences, Inc. · 1999
- Three-dimensional cell and tissue culture system258US 5,443,950 AAdvanced Tissue Sciences, Inc. · 1995
- Three-dimensional culture of pancreatic parenchymal cells cultured living stromal tissue prepared in vitro220US 6,022,743 AAdvanced Tissue Sciences, Inc. · 2000